Home/Alveron Pharma/Ben Nichols

BN

Ben Nichols

Chief Executive Officer

Therapeutic Areas

Hematology Neurology Cardiovascular

Alveron Pharma Pipeline

Drug	Indication	Phase
OKL-1111	Anticoagulant reversal for Hemorrhagic Stroke / Intracranial Hemorrhage (ICH)	Pre-clinical

Leadership Team at Alveron Pharma

Chief Operating Officer

Chief Development Officer

Supervisory Board Member

View full Alveron Pharma profile